The company has a registered capital of 317.22 million yuan, currently more than 6,000 employees, and an annual output value of 400 million yuan. Its main economic indicators rank among the best in the pharmaceutical industry in Henan Province. In 2001, it was certified by the Ministry of Science and Technology and was recognized. It is a key high-tech enterprise in the National Torch Plan. In 2003, it was rated as a "National Tax Inspection-Exempt Enterprise" by the Zhengzhou Municipal State Taxation Bureau. In the same year, it was awarded the "Zhengzhou City Outstanding Enterprise Title" and was rated as a "National High-tech Industrialization Demonstration Project" by the National Development and Reform Commission. The company's registered trademark was also approved by the Henan Provincial Administration for Industry and Commerce. The Administration Bureau recognized it as a "Famous Trademark of Henan Province". In 2006, it was approved as a postdoctoral workstation branch by the Ministry of Personnel.

Henan Tailong Pharmaceutical Co., Ltd. (formerly Henan Zhulin Zhongsheng Pharmaceutical Co., Ltd.) was approved by the Henan Provincial Economic System Reform Commission (1998) No. 38, and is mainly controlled by Zhengzhou Zhongsheng Industrial Group Co., Ltd. The initiator is a joint-stock company jointly established by five companies including Henan Zhiyi Investment and Development Co., Ltd., Zhengzhou Zhulin Xianzhu Cleaning Products Co., Ltd., Zhengzhou Zhulin Refractory Materials Company, and Gongyi Zhulin Xinhua Packaging Materials Factory. . The company was established on August 31, 1998. Approved by the China Securities Regulatory Commission's Zhengjianfa [1999] No. 98 document, the company issued 35 million public shares on August 13, 1999. On March 24, 2006, the company name was changed from "Henan Zhulin Zhongsheng Pharmaceutical Co., Ltd." to "Henan Tailong Pharmaceutical Co., Ltd." The company's current main products include Shuanghuanglian oral liquid series, Shuangjin Lianji, Qingrejiedu oral liquid, Xiere mixture, Children's Qingrezhicough oral liquid, Children's antipyretic oral liquid, Compound Yimu oral liquid, Wujin oral liquid, Jinguo Yin oral liquid, Shengmaiyin oral liquid, Maiwei Dihuang oral liquid, Shuanghuanglian capsules, Haboyin tablets, Zhulinamine tablets, Chuanhuning and other Chinese and Western medicine varieties, including oral liquid, capsules, tablets, infusion and other dosage forms. Among them, Shuanghuanglian Oral Liquid is mainly used to treat pneumonia, tracheitis, pharyngitis, tonsillitis and other upper respiratory tract infections caused by viral and bacterial infections, as well as fever, sore throat, cough and senile asthma caused by colds and viral influenza. It has unique antibacterial properties. , antiviral efficacy, and is listed as a protected species of Chinese medicine by the state. It has won the gold medal of the first China Golden List Technology and Product Expo, the first prize of Zhengzhou Excellent Product and the title of Zhengzhou Famous Brand Product. It has been recognized as a high-tech product by the Henan Provincial Science and Technology Commission. In 1998, it was evaluated by the Henan Provincial Medical Administration Bureau as the only traditional Chinese medicine oral liquid that entered the Henan brand products in 1998. In November 2000, it was recognized as a "Henan Famous Product" by the Henan Provincial Administration of Industry and Commerce and was included in the "National Medical Insurance Drug Catalog".

Shuangjinlianheji, a new broad-spectrum antiviral and antibacterial drug, is mainly used to treat fever, cough, sore throat and other symptoms caused by exogenous wind-cold evil. It is an alternative product to Shuanghuanglian Oral Liquid independently developed by the company, and is similar to Shuanghuanglian Oral Liquid. In comparison, it has the advantages of strong antiviral effect, fast fever reduction, no rebound, and early recovery. Its antipyretic effect is comparable to that of similar chemical drugs. This product will gradually become the company's new main product pillar.

Haberin is a reversible and potent acetylcholinesterase inhibitor that can promote memory reappearance and enhance memory retention. The drug is internationally recognized for the treatment of middle-aged and elderly memory disorders and various types of memory disorders. Dementia is a safe and effective drug for memory, cognitive function and emotional and behavioral disorders. It has obvious effects on improving memory, preventing and treating dementia. In 1997, it was rated as a national new product by the State Economic and Trade Commission. Bambooamine is a high-quality and highly effective adrenergic α-receptor blocker. It is particularly effective in urinating difficulties caused by non-mechanical obstruction caused by prostatic hyperplasia. It has been designated as a recommended product by the Shanghai Branch of the Chinese Medical Association and has successively won national awards. The second prize of the National Science and Technology Progress Award, the first prize of the Henan Province Science and Technology Progress Award, the Provincial Famous and Excellent Products, the first prize of the Municipal Science and Technology Progress Award, etc. The company's current production workshops for its main dosage forms have passed the GMP certification of the State Food and Drug Administration. In product quality control, the company thoroughly implements the "Drug Administration Law" and "Good Manufacturing Practices" (GMP), strengthens drug quality awareness, and ensures safe and effective medication. Over the years, the first-time pass rate of product quality has reached 100%.